CompoAtlas

Magnésium Bisglycinate et Cofacteur

Food supplement declared in France, declaration No 2024-1-936, decision dated 18 January 2024

Magnésium Bisglycinate et Cofacteur, from BEAVERHILL Distribution SAS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pantothenic acid (vitamin B5), Biotin (vitamin B8), Folate (vitamin B9), Magnesium, Nicotinamide (vitamin B3). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
BEAVERHILL Distribution SAS
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 gélules par jour
Directions for use
3 gélules par jour à répartir dans la journée, avec un verre d’eau, à la fin des repas. (Chez l’enfa
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year)

Declaration 167820, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Taurinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
(6S)-5-methyltetrahydrofolic acid, glucosamine saltFolate (vitamin B9)1,000 µg200 µg
magnesium bisglycinateMagnesium250 mg300 mg
nicotinamideNicotinamide (vitamin B3)900 mg54 mg
thiamin hydrochlorideVitamin B1 (thiamine)no limit (insufficient data)dose annulled by the French Council of State in 2011
riboflavinVitamin B2 (riboflavin)no limit (insufficient data)dose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
cholecalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)

Additives

E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Complément alimentaire à utiliser dans le cadre d’une alimentation diversifiée et équilibrée. Respecter la dose journalière recommandée et tenir hors de portée des enfants. Déconseillé aux enfants de moins de 12 ans et aux femmes enceintes et allaitantes

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Magnésium Bisglycinate et Cofacteur: composition and regulation”, https://compoatlas.com/en/supplements/products/167820-magnesium-bisglycinate-et-cofacteur, updated 15 November 2026.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line